Company intelligence / Profile preview

Celltechna

Vilnius, Lithuania

Ownership: Private
Development stage: Other

Overview

Celltechna is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the production of Advanced Therapy Medicinal Products (ATMPs). Based in Lithuania, the company provides end-to-end services for the development and manufacturing of gene therapies, cell therapies, and nucleic acid-based products, including viral vectors and mRNA. Celltechna operates out of a state-of-the-art facility designed to meet global GMP standards, supporting biopharmaceutical clients from early-stage process development through to commercial-scale production. The company is a key player in the Baltic life sciences ecosystem, aiming to accelerate the translation of innovative regenerative medicines to the clinic.

Modalities: Gene therapyCell therapyViral vectormRNA-based drugsPlasmid DNA
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Celltechna.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celltechna.

Explore the full profile